Paushak Ltd
Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India.. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907. [1][2]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE Commodities
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Domestic Revenue Share % of total revenue ・Standalone data |
|
|||||||||
| Export Revenue Share % of total revenue ・Standalone data |
||||||||||
| Permanent Employees count ・Standalone data |
||||||||||
| R&D Spend ₹ Lakhs ・Standalone data |
||||||||||
| Number of International Countries Served count ・Standalone data |
||||||||||
| Phosgene Plant Capacity MT/Year ・Standalone data |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- In accordance with Regulation 30 and Regulation 47 of SEBI Listing Regulations, newspaper advertisement related to Unaudited Financial Results of the Company for the quarter …
-
Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September, 2026.
- Board approved Q2 FY27 unaudited results; revenue Rs 89.32 crore, PAT Rs 13.51 crore.
-
Board Meeting Outcome for Outcome Of Board Meeting
- Board approved unaudited Q2 and half-year results for 30 September 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper publication issued regarding another special window opened for transfer and dematerialization of physical securities.
-
Board Meeting Intimation for Board Meeting To Consider Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2026.
- Board meeting on 16 October 2026 to consider Q2 and half-year unaudited financial results.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Products Portfolio [1] [2]
The company manufactures and supplies phosgene-based specialty chemicals, including chloroformates, isocyanates, chlorides, carbamoyl chlorides, carbonates, and carbamates, serving the pharmaceutical, agrochemical, personal care, polymer, and industrial sectors. It also provides custom synthesis and end-to-end CDMO services, covering process development, feasibility studies, scale-up, commercial manufacturing, quality control, and regulatory support.